D
David J. Margolis
Researcher at University of Pennsylvania
Publications - 581
Citations - 74527
David J. Margolis is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & Atopic dermatitis. The author has an hindex of 97, co-authored 521 publications receiving 62556 citations. Previous affiliations of David J. Margolis include Rutgers University & Harvard University.
Papers
More filters
Journal ArticleDOI
Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers.
J. Bradford Rice,Urvi Desai,Ljubica Ristovska,Alice Kate G. Cummings,Howard G. Birnbaum,Michelle Skornicki,David J. Margolis,Nathan B. Parsons +7 more
TL;DR: It is suggested that use of BLCC and HFDS for treatment of DFU may lower overall medical costs through reduced utilization of costly healthcare services.
Journal ArticleDOI
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults.
Jonathan I. Silverberg,Joel M. Gelfand,David J. Margolis,Mark Boguniewicz,Luz Fonacier,Mitchell H. Grayson,Peck Y. Ong,Zelma C. Chiesa Fuxench,Eric L. Simpson +8 more
TL;DR: It is demonstrated that HADS had good construct validity, and no observed floor or ceiling effects for total scores, but demonstrated differential item functioning for some items in atopic dermatitis.
Economic burden of diabetic foot ulcers and amputations: Data Points #3
David J. Margolis,D. Scot Malay,Ole Hoffstad,Charles E. Leonard,Thomas E. MaCurdy,Yang Tan,Teresa Molina,Karla López de Nava,Karen L Siegel +8 more
TL;DR: In this paper, the authors report that patients with a lower extremity amputation are seen by their outpatient health care provider about 12 times per year and are hospitalized about 2.5 times each year, and the cost of care for these patients is substantial at about $33,000 for total reimbursement of all Medicare services per year.
Journal ArticleDOI
Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
Kenneth A. Katz,Jason Karlawish,David Chiang,Rachel A. Bognet,Katherine J. Propert,David J. Margolis +5 more
TL;DR: Use of placebo controls has been more common in psoriasis trials conducted in the United States and funded by pharmaceutical companies, and the findings suggest that ethical and scientific issues related to choice of control group in psOriasis trials are interpreted markedly differently depending on trial location and funding source.
Journal ArticleDOI
Digital imaging of wounds: are measurements reproducible among observers?
TL;DR: The results demonstrate that digital analysis with WoundMatrix Web is reproducible and precise with acceptable variation among readers, which supports the use of digital images of wounds to follow clinical progress as well as analyze the effects of new clinical interventions in clinical trials.